The effectiveness of hand hygiene interventions for preventing community transmission or acquisition of novel coronavirus or influenza infections: a systematic review.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

COVID-19*/prevention & control ; Hand Hygiene* ; Influenza, Human*/epidemiology ; Influenza, Human*/prevention & control; Humans ; Pandemics/prevention & control ; SARS-CoV-2

Background: Novel coronaviruses and influenza can cause infection, epidemics, and pandemics. Improving hand hygiene (HH) of the general public is recommended for preventing these infections. This systematic review examined the effectiveness of HH interventions for preventing transmission or acquisition of such infections in the community.
Methods: PubMed, MEDLINE, CINAHL and Web of Science databases were searched (January 2002-February 2022) for empirical studies related to HH in the general public and to the acquisition or transmission of novel coronavirus infections or influenza. Studies on healthcare staff, and with outcomes of compliance or absenteeism were excluded. Study selection, data extraction and quality assessment, using the Cochrane Effective Practice and Organization of Care risk of bias criteria or Joanna Briggs Institute Critical Appraisal checklists, were conducted by one reviewer, and double-checked by another. For intervention studies, effect estimates were calculated while the remaining studies were synthesised narratively. The protocol was pre-registered (PROSPERO 2020: CRD42020196525).
Results: Twenty-two studies were included. Six were intervention studies evaluating the effectiveness of HH education and provision of products, or hand washing against influenza. Only two school-based interventions showed a significant protective effect (OR: 0.64; 95% CI 0.51, 0.80 and OR: 0.40; 95% CI 0.22, 0.71), with risk of bias being high (n = 1) and unclear (n = 1). Of the 16 non-intervention studies, 13 reported the protective effect of HH against influenza, SARS or COVID-19 (P < 0.05), but risk of bias was high (n = 7), unclear (n = 5) or low (n = 1). However, evidence in relation to when, and how frequently HH should be performed was inconsistent.
Conclusions: To our knowledge, this is the first systematic review of effectiveness of HH for prevention of community transmission or acquisition of respiratory viruses that have caused epidemics or pandemics, including SARS-CoV-1, SARS-CoV-2 and influenza viruses. The evidence supporting the protective effect of HH was heterogeneous and limited by methodological quality; thus, insufficient to recommend changes to current HH guidelines. Future work is required to identify in what circumstances, how frequently and what product should be used when performing HH in the community and to develop effective interventions for promoting these specific behaviours in communities during epidemics.
(© 2022. The Author(s).)

BMC Infect Dis. 2020 Aug 17;20(1):607. (PMID: 32807087)
BMC Public Health. 2021 Apr 29;21(1):827. (PMID: 33926406)
BMJ Glob Health. 2020 Aug;5(8):. (PMID: 32764128)
JAMA Netw Open. 2021 Sep 1;4(9):e2125187. (PMID: 34581798)
Int J Epidemiol. 2020 Jun 1;49(3):717-726. (PMID: 32086938)
Int J Behav Nutr Phys Act. 2016 Dec 7;13(1):127. (PMID: 27927218)
Emerg Infect Dis. 2011 Apr;17(4):619-25. (PMID: 21470450)
Infect Control Hosp Epidemiol. 2009 Jul;30(7):611-22. (PMID: 19508124)
BMC Public Health. 2015 Jun 09;15:543. (PMID: 26055522)
J Med Virol. 2021 May;93(5):3033-3046. (PMID: 33538342)
Trop Med Int Health. 2015 Jun;20(6):719-29. (PMID: 25682788)
Cureus. 2020 Sep 29;12(9):e10707. (PMID: 33014665)
BMJ Open. 2011 Nov 24;1(2):e000127. (PMID: 22116088)
PLoS One. 2020 Dec 8;15(12):e0242403. (PMID: 33290402)
Pediatr Infect Dis J. 2011 Nov;30(11):921-6. (PMID: 21691245)
Emerg Infect Dis. 2020 Nov;26(11):2607-2616. (PMID: 32931726)
J Antimicrob Chemother. 2018 Jun 1;73(6):1464-1478. (PMID: 29554263)
Cureus. 2021 Feb 1;13(2):e13064. (PMID: 33680606)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
BMC Public Health. 2021 Sep 25;21(1):1745. (PMID: 34563144)
Public Health Rep. 2010 Mar-Apr;125(2):178-91. (PMID: 20297744)
Lancet Infect Dis. 2013 Oct;13(10):843-51. (PMID: 23972825)
Cochrane Database Syst Rev. 2020 Nov 20;11:CD006207. (PMID: 33215698)
Influenza Other Respir Viruses. 2013 Mar;7(2):177-83. (PMID: 22458533)
Am J Trop Med Hyg. 2019 Dec;101(6):1446-1455. (PMID: 31701861)
Emerg Infect Dis. 2004 Apr;10(4):587-92. (PMID: 15200846)
Pediatr Infect Dis J. 2021 Oct 1;40(10):e379-e381. (PMID: 34387617)
Jpn J Infect Dis. 2021 Sep 22;74(5):405-410. (PMID: 33518620)
Infect Control Hosp Epidemiol. 2002 Dec;23(12 Suppl):S3-40. (PMID: 12515399)
CMAJ. 2006 Nov 7;175(10):1219-23. (PMID: 17098951)
Prev Med. 2012 Jun;54(6):434-9. (PMID: 22548868)
Ann Intern Med. 2009 Oct 6;151(7):437-46. (PMID: 19652172)
Emerg Infect Dis. 2004 Feb;10(2):210-6. (PMID: 15030685)
Bull Hist Med. 2002 Spring;76(1):105-15. (PMID: 11875246)
PLoS One. 2015 Jun 11;10(6):e0125200. (PMID: 26066651)
PLoS One. 2013 Oct 18;8(10):e77873. (PMID: 24205006)

Keywords: COVID-19; Community acquisition; Community transmission; Hand hygiene; Hand washing; Influenza; SARS-CoV-1; SARS-CoV-2; Systematic review

Date Created: 20220702 Date Completed: 20220707 Latest Revision: 20240831

20250114

PMC9250256

10.1186/s12889-022-13667-y

35780111